BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dufresne A, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Frezza AM, Gasperoni S, Gelderblom H, Gouin F, Grignani G, Haas R, Hassan AB, Hindi N, Hohenberger P, Joensuu H, Jones RL, Jungels C, Jutte P, Kasper B, Kawai A, Kopeckova K, Krákorová DA, Le Cesne A, Le Grange F, Legius E, Leithner A, Lopez-Pousa A, Martin-Broto J, Merimsky O, Messiou C, Miah AB, Mir O, Montemurro M, Morosi C, Palmerini E, Pantaleo MA, Piana R, Piperno-Neumann S, Reichardt P, Rutkowski P, Safwat AA, Sangalli C, Sbaraglia M, Scheipl S, Schöffski P, Sleijfer S, Strauss D, Strauss SJ, Hall KS, Trama A, Unk M, van de Sande MAJ, van der Graaf WTA, van Houdt WJ, Frebourg T, Gronchi A, Stacchiotti S; ESMO Guidelines Committee, EURACAN and GENTURIS. Electronic address: clinicalguidelines@esmo.org. Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021:S0923-7534(21)04480-X. [PMID: 34560242 DOI: 10.1016/j.annonc.2021.09.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
Number Citing Articles
1 Baek WK, Ni P, Zeng J, Collins V, Zeizafoun N. A Rare Case of Breast Metastatic Gastrointestinal Stromal Tumor. Cureus 2023. [DOI: 10.7759/cureus.34164] [Reference Citation Analysis]
2 Sasaki K, Kanda T, Matsumoto Y, Ishikawa T, Hirota S, Saijo Y. Sunitinib therapy for imatinib-resistant and/or intolerant gastrointestinal stromal tumors: comparison of safety and efficacy between standard and reduced dosage regimens. Jpn J Clin Oncol 2023:hyac202. [PMID: 36644881 DOI: 10.1093/jjco/hyac202] [Reference Citation Analysis]
3 Zhang C, Wang J, Yang Y, Dai B, Xu Z, Zhu F, Yu H. Machine learning for predicting the risk stratification of 1-5 cm gastric gastrointestinal stromal tumors based on CT.. [DOI: 10.21203/rs.3.rs-2461211/v1] [Reference Citation Analysis]
4 Chien MM, Lin YH, Chang CC, Chien HY. A Rare Gastric Subepithelial Lesion Removed through Submucosal Tunneling Endoscopic Resection: Case Report and Literature Review. Life (Basel) 2023;13. [PMID: 36676128 DOI: 10.3390/life13010179] [Reference Citation Analysis]
5 Schardt L, Kaths M, Bauer S. Molekularpathologisch determinierte multimodale Therapie gastrointestinaler Stromatumoren. Onkologie 2023. [DOI: 10.1007/s00761-022-01297-3] [Reference Citation Analysis]
6 Yip HC, Teh JL, Teoh AYB, Chiu P. Pure endoscopic resection versus laparoscopic assisted procedure for upper gastrointestinal stromal tumors: Perspective from a surgical endoscopist. Dig Endosc 2023;35:184-94. [PMID: 36318279 DOI: 10.1111/den.14463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Blay J, Italiano A, Penel N, Le Loarer F, Karanian M, De Pinieux G, Coindre J, Ducimetiere F, Chemin C, Morelle M, Gouin F, Toulmonde M, Le Cesne A. Impact d’un réseau de centre de référence pour le diagnostic et la prise en charge des patients atteints de sarcomes en France depuis 2010. Bulletin de l'Académie Nationale de Médecine 2023. [DOI: 10.1016/j.banm.2023.01.003] [Reference Citation Analysis]
8 . WEO Newsletter. Dig Endosc 2023;35:152-9. [PMID: 36634912 DOI: 10.1111/den.14491] [Reference Citation Analysis]
9 Fukada A, Takahashi T, Kurokawa Y, Asaoka T, Teranishi R, Saito T, Yamamoto K, Yamashita K, Tanaka K, Makino T, Nakajima K, Umeda D, Morii E, Hirota S, Eguchi H, Doki Y. Laparoscopic resection for recurrent gastrointestinal stromal tumors and paraganglioma in a patient with Carney-Stratakis syndrome: A case report. Asian J Endosc Surg 2023;16:90-4. [PMID: 35793808 DOI: 10.1111/ases.13104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Cui H, Li Y, Huang W, Lu W, Yi X. Escalation of radiotherapy dose in large locally advanced drug-resistant gastrointestinal stromal tumors by multi-shell simultaneous integrated boost intensity-modulated technique: a feasibility study. Radiat Oncol 2022;17:216. [PMID: 36578008 DOI: 10.1186/s13014-022-02179-z] [Reference Citation Analysis]
11 Kanda T, Naito T, Wakai A, Iwafuchi Y, Hirota S, Ajioka Y. Late recurrence of low-risk gastrointestinal stromal tumor of jejunum diagnosed 30 years after tumor resection: A case report and literature review. Oncol Lett 2023;25:50. [PMID: 36644139 DOI: 10.3892/ol.2022.13636] [Reference Citation Analysis]
12 IJzerman NS, van Werkhoven E, Mohammadi M, Hollander DD, Bleckman RF, Reyners AKL, Desar IME, Gelderblom H, Grünhagen DJ, Mathijssen RHJ, Steeghs N, van der Graaf WTA. Sex differences in patients with gastrointestinal stromal tumours: do they exist and does it affect survival? ESMO Open 2022;7:100649. [PMID: 36493601 DOI: 10.1016/j.esmoop.2022.100649] [Reference Citation Analysis]
13 Hu X, Zhang Q, Wang Z, Ren H, Su P, Kou Y. Retrospective study of the clinicopathological characteristics and prognostic factors of gastrointestinal stromal tumors in Chinese patients. Annals of Diagnostic Pathology 2022;61:152050. [DOI: 10.1016/j.anndiagpath.2022.152050] [Reference Citation Analysis]
14 Brinch CM, Hogdall E, Junker N, Moeller HJ, Sandfeld-Paulsen B, de Heer P, Penninga L, Rossen PB, Krarup-Hansen A, Aggerholm-Pedersen N. The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor. Cancers (Basel) 2022;14. [PMID: 36497235 DOI: 10.3390/cancers14235753] [Reference Citation Analysis]
15 Campora M, Paudice M, Gambella A, Comandini D, Parente P, Sbaraglia M, Dei Tos AP, Grillo F, Mastracci L. Counting mitoses in gastrointestinal stromal tumours (GISTs): variable practices in the real-world setting and their clinical implications. Virchows Arch 2022. [DOI: 10.1007/s00428-022-03454-w] [Reference Citation Analysis]
16 Lopes-Brás R, Lopez-Presa D, Esperança-Martins M, Melo-Alvim C, Gallego L, Costa L, Fernandes I. Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic Arsenal. Int J Mol Sci 2022;23. [PMID: 36430703 DOI: 10.3390/ijms232214227] [Reference Citation Analysis]
17 Matli VVK, Zibari GB, Wellman G, Ramadas P, Pandit S, Morris J. A rare synchrony of adenocarcinoma of the ampulla with an ileal gastrointestinal stromal tumor: A case report. World J Gastrointest Oncol 2022; 14(11): 2253-2265 [DOI: 10.4251/wjgo.v14.i11.2253] [Reference Citation Analysis]
18 Murakami K, Kuge H, Koyama F, Obara S, Nakamoto T, Iwasa Y, Takei T, Sadamitsu T, Fujimoto K, Harada S, Sho M. A two-team approach for the complete resection of a bulky gastrointestinal stromal tumor on the anterior wall of the lower rectum after neoadjuvant treatment. Tech Coloproctol 2022. [DOI: 10.1007/s10151-022-02729-3] [Reference Citation Analysis]
19 Wu J, Zhuang M, Zhou Y, Zhan X, Xie W. The value of contrast-enhanced harmonic endoscopic ultrasound in differential diagnosis and evaluation of malignant risk of gastrointestinal stromal tumors (<50mm). Scand J Gastroenterol 2022;:1-7. [PMID: 36369879 DOI: 10.1080/00365521.2022.2144437] [Reference Citation Analysis]
20 Fung S, Shirley M. Ripretinib: A Review in Gastrointestinal Stromal Tumours as Fourth-or Later-Line of Therapy. Drugs 2022. [DOI: 10.1007/s40265-022-01794-0] [Reference Citation Analysis]
21 Freund MR, Emile SH, Horesh N, Garoufalia Z, Gefen R, Wexner SD. The importance of surgical resection in the management of rectal sarcoma: A national cancer database analysis of 133 cases. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.10.014] [Reference Citation Analysis]
22 Li W, Li X, Yu K, Xiao B, Peng J, Zhang R, Zhang L, Wang K, Pan Z, Li C, Wu X. Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study. Front Pharmacol 2022;13:950101. [DOI: 10.3389/fphar.2022.950101] [Reference Citation Analysis]
23 Snegarova V, Miteva D, Gulinac M, Peshevska-Sekulovska M, Batselova H, Velikova T. COVID-19 in patients with gastrointestinal stromal tumors: Recommendations for management and vaccination. World J Gastrointest Pathophysiol 2022; 13(5): 170-177 [DOI: 10.4291/wjgp.v13.i5.170] [Reference Citation Analysis]
24 Fiorino E, Merlini A, D’ambrosio L, Cerviere I, Berrino E, Marchiò C, Giraudo L, Basiricò M, Massa A, Donini C, Leuci V, Rotolo R, Galvagno F, Vitali L, Proment A, Ferrone S, Pisacane A, Pignochino Y, Aglietta M, Grignani G, Mesiano G, Sangiolo D. Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST. IJMS 2022;23:10368. [DOI: 10.3390/ijms231810368] [Reference Citation Analysis]
25 Hu X, Wang Z, Su P, Zhang Q, Kou Y. Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors. Front Oncol 2022;12:933248. [DOI: 10.3389/fonc.2022.933248] [Reference Citation Analysis]
26 Wang P, Chen E, Xie M, Xu W, Ou C, Zhou Z, Niu Y, Song W, Ni Q, Zhu J. The Number of Lymph Nodes Examined is Associated with Survival Outcomes of Neuroendocrine Tumors of the Jejunum and Ileum (siNET): Development and Validation of a Prognostic Model Based on SEER Database. J Gastrointest Surg 2022;26:1917-29. [PMID: 35689008 DOI: 10.1007/s11605-022-05359-0] [Reference Citation Analysis]
27 Spierenburg G, Grimison P, Chevreau C, Stacchiotti S, Piperno-Neumann S, Le Cesne A, Ferraresi V, Italiano A, Duffaud F, Penel N, Metzger S, Chabaud S, van der Heijden L, Pérol D, van de Sande MAJ, Blay JY, Gelderblom H. Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: Long-term follow-up of nilotinib in TGCT. Eur J Cancer 2022;173:219-28. [PMID: 35932628 DOI: 10.1016/j.ejca.2022.06.028] [Reference Citation Analysis]
28 Papadakos SP, Tsagkaris C, Papadakis M, Papazoglou AS, Moysidis DV, Zografos CG, Theocharis S. Angiogenesis in gastrointestinal stromal tumors: From bench to bedside. World J Gastrointest Oncol 2022; 14(8): 1469-1477 [DOI: 10.4251/wjgo.v14.i8.1469] [Reference Citation Analysis]
29 Cao Y, Zhang X, Chen Q, Rao X, Qiu E, Wu G, Lin Y, Zeng Z, Zheng B, Li Z, Cai Z, Wang H, Han S. Patient-Derived Organoid Facilitating Personalized Medicine in Gastrointestinal Stromal Tumor With Liver Metastasis: A Case Report. Front Oncol 2022;12:920762. [DOI: 10.3389/fonc.2022.920762] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mas L, Bachet J. GIST avancées : quels traitements en 2022. Bulletin du Cancer 2022. [DOI: 10.1016/j.bulcan.2022.06.009] [Reference Citation Analysis]
31 Goggin C, Stansfeld A, Mahalingam P, Thway K, Smith MJ, Huang P, Jones RL, Napolitano A. Ripretinib in advanced gastrointestinal stromal tumors: an overview of current evidence and drug approval. Future Oncol 2022. [PMID: 35880452 DOI: 10.2217/fon-2022-0226] [Reference Citation Analysis]
32 Jiang X, Xiong F, Fu Q, Peng H, Jing Y, Rexiti K, Wei X, Tao S. Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis. Int J Colorectal Dis 2022. [PMID: 35780257 DOI: 10.1007/s00384-022-04214-7] [Reference Citation Analysis]
33 Sobczuk P, Bątruk H, Wójcik P, Iwaniak K, Kozak K, Rutkowski P. In search of effective therapies: the current landscape of phase II trials in patients with advanced soft tissue sarcoma. J Cancer Res Clin Oncol 2022. [PMID: 35778653 DOI: 10.1007/s00432-022-04149-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Murphy AN, Kearns C. Gastrointestinal Stromal Tumors and their Appearance in Patients with Neurofibromatosis Type 1. Radiographics 2022;42:E111-2. [PMID: 35594199 DOI: 10.1148/rg.220062] [Reference Citation Analysis]
35 Zhang H, Jiang T, Mu M, Zhao Z, Yin X, Cai Z, Zhang B, Yin Y. Radiotherapy in the Management of Gastrointestinal Stromal Tumors: A Systematic Review. Cancers 2022;14:3169. [DOI: 10.3390/cancers14133169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Dudzisz-Śledź M, Klimczak A, Bylina E, Rutkowski P. Treatment of Gastrointestinal Stromal Tumors (GISTs): A Focus on Younger Patients. Cancers (Basel) 2022;14:2831. [PMID: 35740497 DOI: 10.3390/cancers14122831] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Nishida T, Sato S, Ozaka M, Nakahara Y, Komatsu Y, Kondo M, Cho H, Hirota S, Kagimura T, Kurokawa Y, Kitagawa Y; The STAR ReGISTry Investigators. Long-term adjuvant therapy for high-risk gastrointestinal stromal tumors in the real world. Gastric Cancer. [DOI: 10.1007/s10120-022-01310-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Li H, Ren H, Sun H, Song L, Wang Y, Yang J, Sun P, Cui Y. Jejunojejunal intussusception with chronic bleeding caused by gastrointestinal stromal tumor: a case report and literature review. J Gastrointest Oncol 2022;13:1481-8. [PMID: 35837170 DOI: 10.21037/jgo-22-301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Tarallo M, Carruezzo C, Dentice Di Accadia FM, Del Gaudio A, Caruso D, Polici M, Crocetti D, Costi U, Polistena A, Panzuto F, Laghi A, Cavallaro G, Fiori E. A Case Report of Multiple Gastrointestinal Stromal Tumors: Imaging Findings, Surgical Approach, and Review of the Literature. Front Surg 2022;9:886135. [DOI: 10.3389/fsurg.2022.886135] [Reference Citation Analysis]
40 Sharma AK, Kim TS, Bauer S, Sicklick JK. Gastrointestinal Stromal Tumor. Surgical Oncology Clinics of North America 2022. [DOI: 10.1016/j.soc.2022.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 van de Wal D, Elie M, Le Cesne A, Fumagalli E, den Hollander D, Jones RL, Marquina G, Steeghs N, van der Graaf WTA, Husson O. Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature. Cancers (Basel) 2022;14:1832. [PMID: 35406604 DOI: 10.3390/cancers14071832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Zhang Y, Renberg S, Papakonstantinou A, Haglund de Flon F. Diagnosing gastrointestinal stromal tumors: The utility of fine-needle aspiration cytology versus biopsy. Cancer Med 2022. [PMID: 35301817 DOI: 10.1002/cam4.4630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Foo T, Goldstein D, Segelov E, Shapiro J, Pavlakis N, Desai J, Yip D, Zalcberg J, Price TJ, Nagrial A, Chantrill L, Burge M, Karapetis CS, Tebbutt N, Roy AC. The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours. Target Oncol 2022. [PMID: 35290591 DOI: 10.1007/s11523-022-00869-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 de Nonneville A, Finetti P, Picard M, Monneur A, Pantaleo MA, Astolfi A, Ostrowski J, Birnbaum D, Mamessier E, Bertucci F. CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response. Cancers (Basel) 2022;14:1306. [PMID: 35267618 DOI: 10.3390/cancers14051306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Klug LR, Khosroyani HM, Kent JD, Heinrich MC. New treatment strategies for advanced-stage gastrointestinal stromal tumours. Nat Rev Clin Oncol 2022. [PMID: 35217782 DOI: 10.1038/s41571-022-00606-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
46 de Bernardi A, Dufresne A, Mishellany F, Blay JY, Ray-Coquard I, Brahmi M. Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond. Cancers (Basel) 2022;14:1064. [PMID: 35205812 DOI: 10.3390/cancers14041064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
47 Li J, Guo S, Sun Z, Fu Y. Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor. Front Cell Dev Biol 2022;10:808591. [DOI: 10.3389/fcell.2022.808591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 吴 婷. Adjuvant and Neoadjuvant Therapy for Primary Gastrointestinal Stromal Tumors. ACM 2022;12:2075-2083. [DOI: 10.12677/acm.2022.123298] [Reference Citation Analysis]
49 Wardelmann E, Kuntze A, Trautmann M, Hartmann W. [Abdominal soft tissue tumors]. Pathologie (Heidelb) 2022;43:42-9. [PMID: 36222918 DOI: 10.1007/s00292-022-01128-7] [Reference Citation Analysis]
50 Swallow CJ. The enduring decision-making role of the surgeon in the multidisciplinary management of GIST. Ann Oncol 2022;33:17-9. [PMID: 34826575 DOI: 10.1016/j.annonc.2021.11.007] [Reference Citation Analysis]
51 Willis F, Schneider M. [Retroperitoneal soft tissue sarcoma: surgical management]. Chirurg 2021. [PMID: 34596706 DOI: 10.1007/s00104-021-01506-6] [Reference Citation Analysis]